Insider Transactions Reported by 15 Insiders of Oyster Point Pharma, Inc.

Location
Princeton, NJ

There are no Buy or Sell transactions made by insiders since 14 Feb 2025

Oyster Point Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
WILLIAM J. LINK PHD Director $5,467,492 05 Jan 2022
John Snisarenko Chief Commercial Officer $339,606 09 Jan 2022
Benjamin Tsai Director 03 Jan 2023
George Christopher Eliades Director 03 Jan 2023
Daniel Lochner Chief Financial Officer 01 Dec 2022
Jeffrey Nau President and CEO, Director 01 Dec 2022
GP IV L.L.C. InvOpps Director, 10%+ Owner 03 Jan 2023
Clare Ozawa Director 03 Jan 2023
New Enterprise Associates 14, L.P. 10%+ Owner 03 Jan 2023
Donald J. Santel Director 03 Jan 2023
AIMEE S. WEISNER Director 03 Jan 2023
Versant Venture Capital VI, L.P. 10%+ Owner 03 Jan 2023
Ali Behbahani Director 03 Jan 2023
MICHAEL G. ATIEH Director 03 Jan 2023
Mark Anthony Murray Director 03 Jan 2023

Recent Insider Transactions by Companies or Individuals for Oyster Point Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.